Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants

dc.contributor.authorSpoulou, V.en
dc.contributor.authorVictoratos, P.en
dc.contributor.authorIoannidis, J. P.en
dc.contributor.authorGrafakos, S.en
dc.date.accessioned2015-11-24T19:08:30Z
dc.date.available2015-11-24T19:08:30Z
dc.identifier.issn0022-1899-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20535
dc.rightsDefault Licence-
dc.subjectAntibodies, Bacterial/*biosynthesisen
dc.subjectBacterial Vaccines/*immunologyen
dc.subjectBone Marrow Transplantation/*immunologyen
dc.subjectCD4-CD8 Ratioen
dc.subjectChilden
dc.subjectHaemophilus Vaccines/immunologyen
dc.subjectHaemophilus influenzaeen
dc.subjectHumansen
dc.subjectKineticsen
dc.subjectMaleen
dc.subjectPneumococcal Infections/*prevention & controlen
dc.subjectRisk Factorsen
dc.subjectStreptococcus pneumoniae/*immunologyen
dc.subjectTime Factorsen
dc.titleKinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplantsen
heal.abstractThe kinetics of the immune response to the 23-valent pneumococcal polysaccharide vaccine (PPV) were studied in 38 children who received bone marrow transplants (BMTs). Anti-pneumococcal antibody concentrations increased 1 and 3 months after vaccination for all 5 serotypes tested, but, in 21 children, the vaccine was not adequately immunogenic. Children vaccinated <18 months after receiving a BMT had a 4.2-fold increased odds of poor response (P=. 06). Antibody concentrations returned close to baseline levels 9 months after vaccination. Avidity declined significantly as early as 1 month after vaccination and remained low thereafter. Antibody concentration responses to PPV were superior among 9 healthy control children (P=.001); 37 of 38 children with a BMT elicited adequate, persistent immune responses to Haemophilus influenzae conjugate vaccine. Immune responses to PPV in children with a BMT are suboptimal, short lived, and associated with declining avidity. The different kinetics of antibody concentration and avidity indicate that both markers should be used for evaluating pneumococcal vaccines in this high-risk population.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1086/315798-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10950799-
heal.identifier.secondaryhttp://jid.oxfordjournals.org/content/182/3/965.full.pdf-
heal.journalNameJ Infect Disen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2000-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: